Esketamine

CHEMBL395091 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
237.7 g/mol
LogP
2.2
Phase
4

This medication works rapidly on NMDA receptors in the brain to relieve symptoms of severe or treatment-resistant depression. Unlike traditional antidepressants, it can begin to reduce depressive symptoms within hours.

น้ำหนักโมเลกุล

237.7200 g/mol

LogP

2.20

TPSA

29.10 Ų

Lipinski RO5

ผ่าน

ด้านการรักษา

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN[C@]1(c2ccccc2Cl)CCCCC1=O

InChI

InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1

Molecular Formula

C13H16ClNO

HBD / HBA

1 / 2

พันธะที่หมุนได้

2

อะตอมหนัก

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This medication works rapidly on NMDA receptors in the brain to relieve symptoms of severe or treatment-resistant depression. Unlike traditional antidepressants, it can begin to reduce depressive symptoms within hours.

Yes, Esketamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL395091. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 182137. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.